Robert Chess - Net Worth and Insider Trading
Robert Chess Net Worth
The estimated net worth of Robert Chess is at least $3 Million dollars as of 2024-11-10. Robert Chess is the Director of Twist Bioscience Corp and owns about 64,169 shares of Twist Bioscience Corp (TWST) stock worth over $3 Million. Robert Chess is also the Director of Nektar Therapeutics and owns about 259,473 shares of Nektar Therapeutics (NKTR) stock worth over $363,262. Details can be seen in Robert Chess's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Chess has not made any transactions after 2024-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Chess
Robert Chess Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Chess owns 2 companies in total, including Nektar Therapeutics (NKTR) , and Twist Bioscience Corp (TWST) .
Click here to see the complete history of Robert Chess’s form 4 insider trades.
Insider Ownership Summary of Robert Chess
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2024-06-14 | director & Executive Chairman |
| TWST | Twist Bioscience Corp | 2024-02-08 | director |
Robert Chess Latest Holdings Summary
Robert Chess currently owns a total of 2 stocks. Among these stocks, Robert Chess owns 64,169 shares of Twist Bioscience Corp (TWST) as of February 8, 2024, with a value of $3 Million and a weighting of 88.91%. Robert Chess also owns 259,473 shares of Nektar Therapeutics (NKTR) as of June 14, 2024, with a value of $363,262 and a weighting of 11.09%.
Latest Holdings of Robert Chess
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TWST | Twist Bioscience Corp | 2024-02-08 | 64,169 | 45.37 | 2,911,348 |
| NKTR | Nektar Therapeutics | 2024-06-14 | 259,473 | 1.40 | 363,262 |
Holding Weightings of Robert Chess
Robert Chess Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Chess has made a total of 9 transactions in Twist Bioscience Corp (TWST) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Twist Bioscience Corp is the sale of 4,110 shares on February 8, 2024, which brought Robert Chess around $143,768.
According to the SEC Form 4 filings, Robert Chess has made a total of 13 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Nektar Therapeutics is the sale of 19,500 shares on June 14, 2024, which brought Robert Chess around $23,400.
Insider Trading History of Robert Chess
- 1
Robert Chess Trading Performance
Robert Chess Ownership Network
Ownership Network List of Robert Chess
Ownership Network Relation of Robert Chess
Robert Chess Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Robert Chess is the director & Executive Chairman of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Robert Chess made 1 insider transaction in Nektar Therapeutics (NKTR) with a net sale of 19,500. Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 111,800 shares made by Howard W Robin , a net sale of 52,375 shares made by Jonathan Zalevsky , and a net sale of 41,460 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 27,398 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 27,398 shares. During the past 18 months, 289,853 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 289,853 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Robert Chess Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Chess. Currently GuruFocus does not have mailing address information for Robert Chess.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
